Scientists at Delix Therapeutics and UC Davis have engineered a modified LSD compound called JRT by altering just two atoms. This innovation preserves the therapeutic potential of LSD—boosting mood and cognition—while eliminating the hallucinogenic effects. It’s part of a new wave of “non-hallucinogenic psychedelics” that could revolutionize treatment for depression, schizophrenia, and PTSD by enhancing brain plasticity without the trip. #LSDResearch #NeuroScience #MentalHealthInnovation #NonHallucinogenic #Psychoplastogens #DepressionTreatment